scholarly journals Old and new risk factors for upper extremity deep venous thrombosis

2005 ◽  
Vol 3 (11) ◽  
pp. 2471-2478 ◽  
Author(s):  
J. W. BLOM ◽  
C. J. M. DOGGEN ◽  
S. OSANTO ◽  
F. R. ROSENDAAL
2016 ◽  
Vol 11 (1) ◽  
pp. 28-32
Author(s):  
Camelia C. DIACONU ◽  
◽  
Mădălina ILIE ◽  
Mihaela Adela IANCU ◽  
◽  
...  

Upper extremity deep venous thrombosis is a condition with increasing prevalence, with high risk of morbidity and mortality, due to embolic complications. In the majority of the cases, thrombosis involves more than one venous segment, most frequently being affected the subclavian vein, followed by internal jugular vein, brachiocephalic vein and basilic vein. Upper extremity deep venous thrombosis in patients without risk factors for thrombosis is called primary deep venous thrombosis and includes idiopathic thrombosis and effort thrombosis. Deep venous thrombosis of upper extremity is called secondary when there are known risk factors and it is encountered mainly in older patients, with many comorbidities. The positive diagnosis is established only after paraclinical and imaging investigations, ultrasonography being the most useful diagnostic method. The most important complication, with high risk of death, is pulmonary embolism. Treatment consists in anticoagulant therapy, for preventing thrombosis extension and pulmonary embolism.


2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e18190-e18190 ◽  
Author(s):  
Christina Poh ◽  
Ann Brunson ◽  
Anjlee Mahajan ◽  
Theresa Keegan ◽  
Ted Wun

e18190 Background: Upper extremity deep venous thrombosis (UE DVT) is a known complication in patients with cancer. However, the cumulative incidence by cancer type, risk factors associated with UE DVT and impact on survival is not well-described. Methods: Using the California Cancer Registry , we identified patients with 10 common malignancies (2005-2014) and linked this to the California hospitalization and emergency department databases to find patients with an incident UE DVT event using specific ICD-9-CM codes. We determined cumulative incidence of UE DVT adjusted for the competing risk of death. Using Cox proportional hazards regression, stratified by tumor type and adjusted for other prognostic covariates including central venous catheters (CVC), we identified risk factors for developing UE DVT and the impact of UE DVT on overall survival. Patients with venous thromboembolism prior to malignancy diagnosis were excluded. Results: Among 785,444 patients with malignancy, 6,099 (0.8%) had an incident UE DVT. The 24-month cumulative incidence of UE DVT varied by cancer type (Table). Most UE DVT (62.2%) occurred in patients with CVC. VTE after cancer diagnosis and CVC substantially increased the risk for UE DVT across all cancers. UE DVT was also associated with worse overall survival for all malignancies with hazard ratios ranging from 1.52 to 3.72. Conclusions: UE DVT is a rare but important complication among patients with malignancy, with incidence highest in leukemia and lowest in prostate cancer. Although uncommon, UE DVT may affect prognosis in patients with malignancy as it is associated with an increased hazard of death. Table: 24-month cumulative incidence of UE DVT, adjusted for the competing risk of death, in 10 common malignancies among California cancer patients, 2005-2014. [Table: see text]


2021 ◽  
Vol Volume 14 ◽  
pp. 2637-2644
Author(s):  
Scarlett Tohme ◽  
Aparna Vancheswaran ◽  
Kyle Mobbs ◽  
Jessica Kydd ◽  
Nisha Lakhi

2017 ◽  
Vol 5 (6) ◽  
pp. 906-907
Author(s):  
O. Tabatabaie ◽  
G.G. Kasumova ◽  
T.S. Kent ◽  
M.F. Eskander ◽  
A.B. Fadayomi ◽  
...  

2006 ◽  
Vol 4 (4) ◽  
pp. 923-924 ◽  
Author(s):  
J. W. BLOM ◽  
C. J. VAN ROODEN ◽  
C. J. M. DOGGEN ◽  
F. R. ROSENDAAL

2005 ◽  
Vol 41 (3) ◽  
pp. 476-478 ◽  
Author(s):  
Anil Hingorani ◽  
Enrico Ascher ◽  
Natalia Markevich ◽  
William Yorkovich ◽  
Richard Schutzer ◽  
...  

Vascular ◽  
2019 ◽  
Vol 28 (2) ◽  
pp. 183-188
Author(s):  
Katherine Teter ◽  
Frank Arko ◽  
Patrick Muck ◽  
Patrick J Lamparello ◽  
Minhaj S Khaja ◽  
...  

Objectives Venous thoracic outlet syndrome, known by the eponym Paget–Schroetter syndrome, is seen in healthy, young individuals with “effort-induced thrombosis.” Endovascular therapies, including catheter-directed thrombolysis, have been described in the acute management of the upper extremity deep venous thrombosis; however, we assessed the technical success of treating this entity using a mechanical aspiration thrombectomy system. Methods This was a multi-center retrospective review of patients with venous thoracic outlet syndrome with acute thrombosis treated with the Indigo continuous aspiration mechanical thrombectomy system. Charts from patients with venous thoracic outlet syndrome and acute deep venous thrombosis treated with this system at our institution along with three data sharing locations were reviewed for demographics, deep venous thrombosis risk factors, imaging modalities used for diagnosis, extent of axillosubclavian deep venous thrombosis, treatment details, adjunctive therapies, and complications. The primary outcome was technical success (resolution of >70% of thrombus). Results There were 16 patients (50% male) with a mean age of 33 years (range 17–69 years). Six patients had underlying venous thromboembolism risk factors including use of contraceptives ( n = 2), prior deep venous thrombosis ( n = 3), and known thrombophilia ( n = 1). Fifteen patients had complete venous occlusion, and the extent of venous involvement included subclavian ( n = 14), axillary ( n = 16), and brachial ( n = 7). The majority (81.25%) of patients were treated in a single setting, and technical success was achieved in all cases with the use of adjunctive therapies. Only three patients required additional overnight thrombolytic therapy. Conclusions The Penumbra Indigo system, often in combination with adjunctive catheter-directed thrombolysis and venoplasty, is a safe and effective device for the treatment of acute upper extremity deep venous thrombosis in the setting of Paget–Schroetter syndrome. No patients experienced central embolization or post-operative renal insufficiency. One-third of patients avoided any additional catheter-directed thrombolysis exposure, and technical success was achieved in all cases. A single bleeding complication was observed in a patient undergoing overnight adjunctive catheter-directed thrombolysis. All patients maintained patency until time of first rib resection.


Sign in / Sign up

Export Citation Format

Share Document